Matthieu Lewis | Senior Market Strategy Manager - Molecular Diagnostics
Takara Bio Europe

Matthieu Lewis, PhD
Senior Market Strategy Manager, Takara Bio Europe Dr. Matthieu Lewis is a Senior Market Strategy Manager at Takara Bio Europe, where he specializes in advancing market strategies for genetic and molecular biology technologies, including PCR/qPCR products and automation platforms. His scientific expertise spans genetics, infectious diseases, and antimicrobial resistance (AMR) surveillance technologies. Matthieu earned his PhD in Genetics from the University of Bordeaux, France, where his research laid the foundation for his career in molecular biology and its applications in disease understanding and diagnostics. He has made contributions to the field, including the development of simplified and streamlined protocols for COVID-19 testing during the pandemic, collaborating with international experts across the EMEA region. Currently, Matthieu is working closely with Resistomap OY to develop comprehensive solutions for AMR surveillance, particularly focusing on wastewater monitoring. His work aims to streamline and enhance the efficiency of these technologies, which are critical in the global fight against antibiotic resistance. At this conference, Matthieu is keen to explore new technologies and methods that can further improve the effectiveness of wastewater surveillance, aligning with his ongoing efforts in AMR surveillance, and will be chairing a roundtable session on this topic.